Market Tracker

01/26 9:10am ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

125.57
Data as of Jan 23
 -1.73 / -1.36%
Today’s Change
59.79
Today|||52-Week Range
127.69
+5.70%
Year-to-Date

Today’s Trading

Previous close127.30
Today’s open126.72
Day’s range-- - --
Volume977,026
Average volume (3 months)1,528,115
Market cap$30.2B
Dividend yield--
Data as of 01/23/2015

Growth & Valuation

Earnings growth (last year)-296.00%
Earnings growth (this year)-51.13%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-20.63%
P/E ratioNM
Price/Sales13.79
Price/Book21.64

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+3.00+1.66%
ZTSZoetis Inc-0.39-0.88%
PRGOPerrigo Company PLC+0.79+0.51%
MYLMylan Inc-0.23-0.42%
Data as of 01/23/2015

Financials

Next reporting dateJanuary 29, 2015
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$1.2B
Annual profit (last year)-$445.0M
Net profit margin-36.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff M. Leiden
Chief Financial Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Cambridge, Massachusetts

Forecasts